The consensus price target hints at a 95.6% upside potential for Zai Lab Limited (ZLAB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...
Zenas BioPharma, Inc. ("Zenas" or the "Company") , a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...
Fiera Comox Partners Inc. ("Fiera Comox"), an affiliate of Fiera Capital Corporation , is pleased to announce its acquisition of 6,650 acres of private timberlands in the United States. Situated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback